Literature DB >> 17277876

[Ambulatory management of community acquired pneumonia in the elderly].

Philippa Moore1, Juan Pablo Ortega, Fernando Saldías, María Angélica Oyarzún.   

Abstract

Community Acquired Pneumonia (CAP) is the first cause of death by respiratory disease in Chile and the first specific cause of death in people over 80 years of age. The geriatric population has a greater risk of suffering pneumonia, its complications and consequently dying. This is not only related to chronological age but also to certain factors related to ageing such as the presence of comorbidity, malnutrition, and cognitive impairment. An atypical presentation that delays the diagnosis and treatment also increases the risk of complications. CAP in the elderly is caused by the same pathogens that cause it in younger patients. S pneumoniae is the main pathogen followed by viral infections particularly in winter. An important strategy to reduce CAP related health costs, is the identification of patients who are at low risk of complications and who therefore could be managed at home. Optimum management of CAP in the elderly includes early diagnosis and the definition of clinical severity, early antibiotic treatment at the right dose and for an adequate length of time and a correct decision whether the patient should be managed in hospital or at home.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277876     DOI: 10.4067/s0034-98872006001200013

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  1 in total

1.  [Impact of the ERA and GES health programs on mortality from community-acquired pneumonia in persons aged ≥65 years in ChileImpacto do programa de saúde ERA e do GES na mortalidade por pneumonia adquirida na comunidade em indivíduos com idade acima de 65 anos no Chile].

Authors:  José Tomás Valdés; Claudia Contreras; Marcela Cárcamo; Pamela San Martín; Nicolás Valdés; Alyssa Sbarra; María Teresa Valenzuela
Journal:  Rev Panam Salud Publica       Date:  2019-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.